Recombinant Proteins
Harnessing Proteins to Fight Rare & Infectious Diseases
Recombinant protein vaccines are the leading vaccine technology for combating infectious diseases worldwide due to their efficacy, safety, scalability, and ease of storage. Recipharm Advanced Bio, with its expertise and extensive experience in cell culture and downstream purification of recombinant protein vaccines, has been chosen by multiple non-profit organizations, including PATH.org, the GHIT Consortium, and the EU Consortium.
Experience & Flexibility Make Recipharm Advanced Bio the Partner of Choice
With process development support from the Institute of Experimental Biology and Technology (iBET) in Portugal and over 30 years of experience in biologics process development, Recipharm Advanced Bio proudly applies its expertise in recombinant proteins to fight diseases such as malaria and Chagas disease.
We have partnered with and participated in various organizations, including PATH.org, an EU consortium, and the GHIT consortium, to produce clinical GMP products for numerous malaria clinical trials.
- Upstream and downstream process optimization for mammalian, insect, and microbial processes
- Flexible batch sizes
- Molecular biology and cell line development
- Rapid response offering quick turnaround times
Upstream cell culture capacity
| Cell Types | Max Capacity |
|---|---|
| Microbial (bacteria & yeast) | 50 L |
| Mammalian cells | 50 L |
| Insect cells | 200 L |
| Avian cells | 500 L |
Downstream processing capabilities
Purification using depth filtration, tangential flow filtration (TFF) and chromatography systems.
Integrated analytics & quality control
Leveraging state-of-the-art analytical methods and quality systems, Recipharm Advanced Bio has a long history of delivering regulatory excellence for customers worldwide. We manufacture in accordance with stringent cGMP standards, and our facilities are routinely audited by agencies worldwide, ensuring the highest level of regulatory compliance.
Fill-Finish Capacity & Expertise for Recombinant Protein Vaccines
Your recombinant protein vaccine manufacturing partner must offer high-quality, accurate, flexible, and responsive fill-finish capabilities. Recipharm Advanced Bio has the experience and capabilities customers around the world rely on.
- Capable of utilizing a range of vial and syringe formats
- Single-use product flow paths, depending on the configuration
- 0.5% filling tolerance
- Automated batch sizes of up to 30,000 vials
- Semi-automated small batch sizes as small as 100 vials
Recombinant Protein Resources
Advancing Your Program Together
Your program isn’t just another project—it’s a breakthrough in the making. At Recipharm Advanced Bio, we bring deep scientific expertise, innovative thinking, and a problem-solving mindset to every partnership. Whether scaling a complex process, navigating regulatory pathways, or optimizing for commercial success, we’re here to collaborate, adapt, and deliver with excellence.
Let’s push the boundaries of possibility together and bring transformative therapies to patients faster.